Abstract
Background
Atrial substrate remodeling (ASR) was emerged as a critical determinant of very late recurrence (VLR) in paroxysmal atrial fibrillation (PaAF). However, the multifaceted risk factors driving ASR progression and their interplay with clinical outcomes remain incompletely characterized. This study aimed to identify clinical, electrophysiological, and structural risk factors associated with ASR in PaAF patients experiencing VLR after catheter ablation (CA).
Methods
A total of 1786 consecutive patients with PaAF who underwent catheter ablation at Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine between May 2006 and July 2023 were screened. Patients with normal atrial substrate at baseline who subsequently experienced recurrent AF were enrolled and categorized into two cohorts: the ASR group (with ASR) and the NASR group (without ASR). A comparative assessment was performed to identify risk factors, encompassing the recurrent type of arrhythmia, CHA2DS2-VASc score, comorbidities, and pulmonary veins-left atrial (PVs-LA) reconnection, between two groups.
Results
Of 1,786 screened patients, 102 met inclusion criteria (mean age: 61.0 ± 10.0 years; 54% male), with 49 (48%) patients in the ASR group (mean age: 62.1 ± 9.0 years; 45% male) and 53 (52%) in the NASR group (mean age: 61.0 ± 10.0 years; 62% male). The ASR group had a higher CHA2DS2-VASc score, longer recurrence intervals, and a greater prevalence of recurrent persistent AF (PsAF). Notably, recurrent PsAF emerged as an independent risk factor for ASR (HR = 2.66, 95%CI = 1.05–6.73, P = 0.04). Despite the presence of ASR, cardiac function remained preserved in both groups.
Conclusions
In PaAF patients with VLR, recurrent persistent AF is an independent risk factor for atrial substrate remodeling. These findings highlight the role of arrhythmia progression in driving structural-electrical remodeling, even in initially normal atrial substrates.
Key Messages
1. Atrial substrate remodeling significantly contributes to very late PaAF recurrence.
2. The transition from PaAF to PsAF, as a standalone risk factor, accelerates atrial substrate remodeling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer